Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase II Emphasis
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
University of Pittsburgh Tissue Chip Testing Center
The Development Genetics of Butterfly Wing Patterns
Genetic and Pharmacogenetic Modifiers of Cancer Risk and
Signal Transduction in Enterococci
Nonpolar Nucleosides as Probes of Noncovalent Bonding
Recently added grants:
Core A: Automated Cell/Biochemical Assays Core
Protective and pathologic functions of macrophages induced by helminths
Core B: Protein Expression Core
Project 2: Design and screening for immunogens to efficiently elicit anti-HIV-1 bNAbs
Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drugs
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM62201-5-0-2
Application #
7568588
Study Section
Project Start
2006-01-01
Project End
2008-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Early Therapeutics Development with Phase II Emphasis
/ University of Chicago
$662,981
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
Vokes, Everett E. /
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
Comments
Be the first to comment on this grant